Clsi M27-a3
Clsi M27-a3 - Related Videos
09:27
Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins
0 Views •
Cited by 9 •
2014
A rapid and modular protocol for the generation of recombinant vaccinia viruses expressing fluorescently tagged proteins simultaneously using the method of transient dominant selection is described here.
14:47
Population Growth - Student Protocol
0 Views •
2019
Exponential Population Growth Model ExpandNOTE: In these experiments you will use computer software to simulate different types of growth models. HYPOTHESES: The experimental hypothesis might be that if we increase either R, the reproductive rate or the initial population size, NT, that this will increase the population size after 10 generations in an exponential growth model compared to unmanipulated control populations. The null hypothesis may be that populations of different R and initial...
03:38
Polyprotic Acids
0 Views •
2020
Acids are classified by the number of protons per molecule that they can give up in a reaction. Acids such as HCl, HNO3, and HCN that contain one ionizable hydrogen atom in each molecule are called monoprotic acids. Their reactions with water are: Monoprotic acids: Reactions with water HCl (aq) + H2O (l) ⟶ H3O+ (aq) + Cl− (aq) HNO3 (aq) + H2O (l) ⟶ H3O+ (aq) + NO3− (aq) HCN (aq) + H2O (l) ⇌ H3O+ (aq) + CN− (aq) Even though it contains four hydrogen...
01:28
Electron Transport Chains
0 Views •
2019
The final stage of cellular respiration is oxidative phosphorylation that consists of two steps: the electron transport chain and chemiosmosis. The electron transport chain is a set of proteins found in the inner mitochondrial membrane in eukaryotic cells. Its primary function is to establish a proton gradient that can be used during chemiosmosis to produce ATP and generate electron carriers, such as NAD+ and FAD, that are used in glycolysis and the citric acid cycle. The ETC is comprised of...
04:30
Macromolecules - Student Protocol
0 Views •
2019
Identifying Macromolecules with Indicator Solutions ExpandHYPOTHESES: In this activity, the experimental hypothesis might be that the addition of an indicator dye to each test solution will result in a color change if the test solution contains the macromolecule of interest. The null hypothesis might be that the addition of an indicator dye will not result in a color change in any of the test solutions. Place 16 clean test tubes in a tube rack in four rows of four tubes and label each row A...
FAQs
The method exposes a standardized yeast inoculum to progressively different concentrations of an antifungal in broth. After controlled incubation, each concentration is examined for visible fungal growth. The minimum inhibitory concentration, or MIC, is the lowest tested drug concentration associated with the specified growth inhibition, providing a structured measure for comparing isolate responses.
Controlled inoculum size, culture medium, drug concentrations, and incubation conditions reduce variation unrelated to antifungal activity. Using RPMI 1640 broth and standardized yeast preparations helps laboratories assess isolates under comparable conditions. This consistency makes MIC results more reliable for comparisons among laboratories, biological studies, and evaluations of antifungal agents.
An MIC indicates the concentration range at which visible growth inhibition occurs for a particular yeast isolate and antifungal agent combination. Comparing these values helps characterize differences in drug activity and may reveal reduced susceptibility. The result therefore serves as a laboratory measurement of fungal response rather than a direct observation of growth in a patient.
CLSI M27-A3 specifies a consistent broth-dilution framework rather than leaving key testing conditions to individual laboratories. Standardized yeast inocula, RPMI 1640 medium, serial drug concentrations, and controlled incubation create a common basis for interpreting visible inhibition. This structure improves comparability across experiments and reduces uncertainty when laboratories examine the same antifungal activity.
A laboratory prepares a standardized yeast inoculum, combines it with RPMI 1640 broth containing serial concentrations of an antifungal agent, and maintains the cultures under controlled incubation conditions. After incubation, technicians assess visible growth inhibition across the concentration series and record the MIC. These linked steps connect experimental setup with the final susceptibility measurement.
Researchers can apply the method to characterize how fungal isolates respond to antifungal drugs, investigate reduced susceptibility, and support surveillance of emerging resistance. Clinical microbiology laboratories may use the resulting data to inform treatment decisions, while research groups can compare antifungal activity across isolates or support evaluations of new antifungal agents.
Repeated standardized MIC measurements provide comparable observations of isolate responses over time and across laboratories. When results show reduced susceptibility, they can contribute to surveillance of emerging resistance, especially when linked with the tested isolate and antifungal agent. The value of surveillance depends on maintaining consistent testing conditions so apparent changes are not caused by methodological variation.
A standardized broth-dilution procedure gives investigators a common experimental basis for examining the activity of a new antifungal against yeast isolates. Serial concentrations and visible growth-inhibition measurements generate MIC data that can be compared with results from other agents or studies. This comparability supports biological research and helps characterize the agent’s antifungal activity.